2020 had a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 0.23 million in Lithuania, but it has now decreased by 0.96 million (-80.6%).
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Lithuania
No matching regions
Similar regions to Lithuania
Business R&D pharmaceutical in constant PPP $
More indicators for Lithuania
Government R&D in security as % of government support
1.91%
-4.42%
(2021)
Higher-education-finacing R&D financed by general university in local currency
1,069.18M
+108.85M
(2021)
R&D financed by rest of the world in local currency
1,953.96M
+203.99M
(2021)
Government R&D financed by rest of the world in local currency
293.33M
-57.43M
(2021)
Business R&D financed by rest of the world in local currency
1,062.50M
+332.47M
(2021)
Non-profit R&D growth rate
-19.97%
+24.23%
(1999)
Lithuania Business R&D pharmaceutical in constant PPP $ between 2008 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 0.23M | -0.96M |
| 2020 | 1.19M | -5.70M |
| 2019 | 6.90M | +5.25M |
| 2018 | 1.65M | +0.19M |
| 2017 | 1.45M | +0.32M |
| 2016 | 1.14M | -3.91M |
| 2015 | 5.04M | -11.90M |
| 2014 | 16.94M | +11.34M |
| 2013 | 5.60M | -0.61M |
| 2012 | 6.21M | -0.89M |
| 2011 | 7.09M | +0.05M |
| 2010 | 7.04M | -0.40M |
| 2009 | 7.44M | +1.46M |
| 2008 | 5.98M |